BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22183558)

  • 1. Guide to virtual screening: application to the Akt phosphatase PHLPP.
    Sinko W; Sierecki E; de Oliveira CA; McCammon JA
    Methods Mol Biol; 2012; 819():561-73. PubMed ID: 22183558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
    Sierecki E; Sinko W; McCammon JA; Newton AC
    J Med Chem; 2010 Oct; 53(19):6899-911. PubMed ID: 20836557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphatase PHLPP controls the cellular levels of protein kinase C.
    Gao T; Brognard J; Newton AC
    J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of survival signalling pathways by the phosphatase PHLPP.
    O'Neill AK; Niederst MJ; Newton AC
    FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell Signaling.
    Baffi TR; Cohen-Katsenelson K; Newton AC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():723-743. PubMed ID: 32997603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase.
    Sierecki E; Newton AC
    Biochemistry; 2014 Jun; 53(24):3971-81. PubMed ID: 24892992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLPPing through history: a decade in the life of PHLPP phosphatases.
    Grzechnik AT; Newton AC
    Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.
    Andreozzi F; Procopio C; Greco A; Mannino GC; Miele C; Raciti GA; Iadicicco C; Beguinot F; Pontiroli AE; Hribal ML; Folli F; Sesti G
    Diabetologia; 2011 Jul; 54(7):1879-87. PubMed ID: 21461637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
    Rajala RV; Kanan Y; Anderson RE
    Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
    Warfel NA; Newton AC
    J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
    Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
    J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHLiPPing the switch on Akt and protein kinase C signaling.
    Brognard J; Newton AC
    Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
    Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
    J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHLPP-1 negatively regulates Akt activity and survival in the heart.
    Miyamoto S; Purcell NH; Smith JM; Gao T; Whittaker R; Huang K; Castillo R; Glembotski CC; Sussman MA; Newton AC; Brown JH
    Circ Res; 2010 Aug; 107(4):476-84. PubMed ID: 20576936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.
    Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T
    Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning off AKT: PHLPP as a drug target.
    Newton AC; Trotman LC
    Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/threonine kinase akt activation regulates the activity of retinal serine/threonine phosphatases, PHLPP and PHLPPL.
    Kanan Y; Matsumoto H; Song H; Sokolov M; Anderson RE; Rajala RV
    J Neurochem; 2010 Apr; 113(2):477-88. PubMed ID: 20089132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
    Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
    Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of PHLPP phosphatases in the nervous system.
    Mallick A; Sharma M; Dey CS
    Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
    Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
    J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.